Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Spine surgery in the prone position (which involves lying face down) is associated with various visual changes, ranging from temporary changes in acuity (or sharpness) to permanent blindness. Known risk factors include low blood count (anemia) and long surgical times in the prone position under general anesthesia. While blindness is a rare outcome of this surgery, it is devastating and incompletely prevented by controlling known risk factors. Thus, improved monitoring and detection of visual injury during surgery is necessary. The purpose of this study is to determine whether a novel, non-invasive monitoring device can reliably record visual responses during spine surgery. The first phase of this study is completed and involved patients undergoing microdiscectomy surgery. The second phase of this study involves patients undergoing single-level lumbar spine decompression/fusion surgery.
Spine surgery is associated with a variety of post-operative visual complications, ranging from mild, transient deficits in acuity to full visual loss. Known risk factors for visual loss include anemia, hypotension, and long surgical times in the prone position under general anesthesia. Despite recognition and control of risk factors, the prevalence of visual loss after prone spine surgery is estimated at approximately 0.1-1% . The pathophysiology of visual loss most often reflects posterior ischemic optic neuropathy, but anterior ischemic optic neuropathy and posterior reversible encephalopathy syndrome have also been described.
These reports suggest that the entire pathway from retina to visual cortex is vulnerable to injuries causing post-operative visual deficits. The potential for severe injury during spine surgery mandates improved detection of evolving optic tract injury during prone spine surgery.
Theoretically, the flash visual evoked potential (VEP) represents a useful intraoperative tool to monitor global visual system function. However, its application to spine surgery has been limited due to challenges in acquiring and interpreting signals intraoperatively. Several devices for intraoperative VEP-recording have been described . However, most of these have been trialed with patients in the supine or beach chair position, undergoing neurosurgical procedures. Goggle or eyepatch-designed devices have the potential to move during surgery, changing the relationship between the goggle and globe. The goggle itself may potentially compress the globe, producing inconsistent illumination to the retina or causing mechanical injury. These are particular liabilities during changes in position from supine to prone, as is required for many spine surgeries. Additionally, VEPs are extremely variable and exquisitely sensitive to anesthetics- particularly inhaled agents. Consistent with this, intravenous (rather than inhaled) agents have been associated with successful intraoperative VEP monitoring patients, particularly in patients without baseline visual impairment. Nonetheless, there are multiple reports in the literature showing poor correlation/prediction of postoperative visual status by intraoperative VEP measurements. A novel technology for capturing VEPs has recently been developed and may address several of the liabilities described above. The device is constructed from soft foam padding in a "ski mask" design, which we hypothesize may add a measure of protection to the eyes compared to traditional VEP goggles or patches. This design may also provide stability during changes in patient positioning from supine to prone. The front of the mask consists of an opaque circuit board with six bright light emitting diodes positioned in front of each eye, allowing illumination of the retina through closed, protected eyes. Opaque foam separates right and left sides of the mask, allowing each eye to be stimulated individually. To date, the mask has not been tested for sensitivity to elicit and record VEPs in patients under anesthesia. In this pilot study, we tested the feasibility of using the mask during prone spine surgery. Specifically, we asked if VEPs can be detected throughout spine surgeries of varying complexity and duration, whether the signals change with changes in patient positioning and anesthetic conditions, and whether the mask was associated with any adverse effects. Here we show that intraoperative VEPs can be recorded throughout spine surgery using this device. We also describe effects of several anesthetic agents on VEP stability, and ask if there is any qualitative relationship between changes in VEPs and SSEPs recorded simultaneously.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| SightSaver Visual Stimulator | Experimental | A SightSaver Visual Stimulator mask will be applied during surgery. Baseline VEPs will be recorded prior to prone positioning. At the end of surgery, after supine positioning, the SightSaver Visual Stimulator mask will be removed and discarded. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| SightSaver Visual Stimulator | Device | Evoked response photic stimulator |
|
| Measure | Description | Time Frame |
|---|---|---|
| Number of Participants With Presence of VEPs | The primary outcome will be the presence of VEPs during spine surgery. This outcome will be measured in realtime, intraoperatively. Outcome measure: Visual evoked potential morphology, varying in amplitude (µV) and latency. | Duration of surgery (approximately 3 hours) |
| Measure | Description | Time Frame |
|---|---|---|
| Number of Participants With Change in VEP Signal Strength | Number of participants with change in VEP signal strength. This outcome will be measured in realtime, intraoperatively. | Duration of surgery (approximately 3 hours) |
| Correlation of Change in VEPs With Identifiable Intraoperative Event |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| James Beckman, MD | Hospital for Special Surgery, New York | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hospital for Special Surgery | New York | New York | 10021 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 29264762 | Result | Soffin EM, Emerson RG, Cheng J, Mercado K, Smith K, Beckman JD. A pilot study to record visual evoked potentials during prone spine surgery using the SightSaver photic visual stimulator. J Clin Monit Comput. 2018 Oct;32(5):889-895. doi: 10.1007/s10877-017-0092-1. Epub 2017 Dec 20. |
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Intraoperative Monitoring Device | In this study, the FDA-cleared, non-invasive mask called SightSaverTM Visual Stimulator is used as an additional monitor to identify potential changes in the visual system during surgery |
| Title | Milestones | Reasons Not Completed | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
|
Any patient presenting for microdiscectomy, single level lumbar spine decompression/fusion, or multilevel posterior spine fusion
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Evoked Response Photic Stimulator | Arms Assigned Interventions Experimental: SightSaver Visual Stimulator A SightSaver Visual Stimulator mask will be applied during surgery. Baseline VEPs will be recorded prior to prone positioning. At the end of surgery, after supine positioning, the SightSaver Visual Stimulator mask will be removed and discarded. Device: SightSaver Visual Stimulator Evoked response photic stimulator |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Categorical | Count of Participants |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Number of Participants With Presence of VEPs | The primary outcome will be the presence of VEPs during spine surgery. This outcome will be measured in realtime, intraoperatively. Outcome measure: Visual evoked potential morphology, varying in amplitude (µV) and latency. | Patients >18 years old who underwent posterior spine surgery with general anesthesia were enrolled. Surgeries were microdiscectomy or instrumented fusion, irrespective of surgical type or patient position (supine or prone). | Posted | Count of Participants | Participants | Duration of surgery (approximately 3 hours) |
|
Patients were followed up until Post Anesthesia Care Unit (PACU) by the anesthesiologists. A survey was filled out by the anesthesiologists to assure the wellness of the patient. Up to 24 hours after surgery.
This is a pilot study (non-invasive) where there was no treatment involved thus there were no interventions.
There was a 5% incidence of Adverse Event.
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | SightSaver Visual Stimulator | A SightSaver Visual Stimulator mask will be applied during surgery. Baseline VEPs will be recorded prior to prone positioning. At the end of surgery, after supine positioning, the SightSaver Visual Stimulator mask will be removed and discarded. SightSaver Visual Stimulator: Evoked response photic stimulator Adverse event total: 0/20 0% |
Not provided
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Minor periorbital skin irritation. | Skin and subcutaneous tissue disorders | Systematic Assessment | One patient reported minor periorbital skin irritation, which was unaccompanied by physical findings, and resolved fully prior to discharge from the PACU. |
Twenty patients were enrolled but only 18 were analyzed.
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Valeria Rotundo | Hospital for Special Surgery | 212-774-7885 | rotundov@hss.edu |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Whether changes in VEPs vary with any identifiable intraoperative change in patient condition (including hypotension, hypertension, tachycardia, bradycardia, arrhythmias, oxygen saturation, CO2 level, hypothermia and hyperthermia), surgical event (including sudden or ongoing hemorrhage, neurological injury), or anesthetic change (including increasing/decreasing doses of anesthetics, depth of anesthesia and use of vasoactive drugs). This outcome will be measured in realtime, intraoperatively. Number of participants with change in VEPs associated with increases or decreases of isoflurane and nitrous oxide are reported. |
| Duration of surgery (approximately 3 hours) |
| Number of Participants With Intolerance to the SightSaver Visual Stimulator | Whether the SightSaverTM Visual Stimulator is well tolerated by patients. This outcome will be assessed in the PACU will comprise a clinical exam of the periorbital structures and a patient questionnaire | Postoperatively, after recovery from anesthesia (approximately 3 hours after surgery) |
| Participants |
|
| Age, Continuous | Mean | Standard Deviation | Years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Region of Enrollment | Number | participants |
|
|
|
| Secondary | Number of Participants With Change in VEP Signal Strength | Number of participants with change in VEP signal strength. This outcome will be measured in realtime, intraoperatively. | Patients who were >18 years old and were undergoing posterior spine surgery with general anesthesia were approached for the study. Eligible surgeries were microdiscectomy or instrumented fusion (lumbar, thoracic, or thoraco-lumbar). There were no restrictions on the number of surgical levels for inclusion in the study. | Posted | Count of Participants | Participants | Duration of surgery (approximately 3 hours) |
|
|
|
| Secondary | Correlation of Change in VEPs With Identifiable Intraoperative Event | Whether changes in VEPs vary with any identifiable intraoperative change in patient condition (including hypotension, hypertension, tachycardia, bradycardia, arrhythmias, oxygen saturation, CO2 level, hypothermia and hyperthermia), surgical event (including sudden or ongoing hemorrhage, neurological injury), or anesthetic change (including increasing/decreasing doses of anesthetics, depth of anesthesia and use of vasoactive drugs). This outcome will be measured in realtime, intraoperatively. Number of participants with change in VEPs associated with increases or decreases of isoflurane and nitrous oxide are reported. | Correlation of change in VEPs was qualitatively examined in 18 patients, but not systematically quantified. | Posted | Number | participants | Duration of surgery (approximately 3 hours) |
|
|
|
| Secondary | Number of Participants With Intolerance to the SightSaver Visual Stimulator | Whether the SightSaverTM Visual Stimulator is well tolerated by patients. This outcome will be assessed in the PACU will comprise a clinical exam of the periorbital structures and a patient questionnaire | Posted | Count of Participants | Participants | Postoperatively, after recovery from anesthesia (approximately 3 hours after surgery) |
|
|
|
| 0 |
| 20 |
| 0 |
| 20 |
| 1 |
| 20 |
|
Not provided
Not provided